Currently, there are 912.00M common shares owned by the public and among those 910.83M shares have been available to trade.
The company’s stock has a 5-day price change of 1.91% and -0.02% over the past three months. TXN shares are trading 18.37% year to date (YTD), with the 12-month market performance up to 32.13% higher. It has a 12-month low price of $151.27 and touched a high of $220.38 over the same period. TXN has an average intraday trading volume of 5.59 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -1.78%, -1.26%, and 5.12% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Texas Instruments Inc (NASDAQ: TXN) shares accounts for 88.23% of the company’s 912.00M shares outstanding.
It has a market capitalization of $185.77B and a beta (3y monthly) value of 0.96. The stock’s trailing 12-month PE ratio is 37.49, while the earnings-per-share (ttm) stands at $5.38. The company has a PEG of 27.93 and a Quick Ratio of 3.14 with the debt-to-equity ratio at 0.84. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.26% over the week and 2.25% over the month.
Earnings per share for the fiscal year are expected to decrease by -27.95%, and 14.41% over the next financial year. EPS should shrink at an annualized rate of 1.34% over the next five years, compared to 4.81% over the past 5-year period.
Looking at the support for the TXN, a number of firms have released research notes about the stock. Wells Fargo stated their Equal Weight rating for the stock in a research note on November 22, 2024, with the firm’s price target at $215. Citigroup was of a view on August 21, 2024 that the stock is Buy, while Wells Fargo gave the stock Underweight rating on May 16, 2024, issuing a price target of $150. Jefferies on their part issued Hold rating on May 13, 2024.
